FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

783643000: Product containing precisely levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram/1 each conventional release oral tablet (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3759626013 Levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3759627016 Product containing precisely levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Levothyroxine sodium anhydrous true Inferred relationship Some 2
Levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram oral tablet Has manufactured dose form Oral tablet true Inferred relationship Some
Levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram oral tablet This attribute specifies the numerator unit for the presentation strength of a product. mcg true Inferred relationship Some 2
Levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram oral tablet Has presentation strength numerator value 38 false Inferred relationship Some 2
Levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram oral tablet Has presentation strength numerator value neuf false Inferred relationship Some 1
Levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram oral tablet Has presentation strength denominator value un false Inferred relationship Some 1
Levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram oral tablet This attribute specifies the numerator unit for the presentation strength of a product. mcg true Inferred relationship Some 1
Levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram oral tablet This attribute specifies the denominator unit for the presentation strength of a product. Tablet (unit of presentation) true Inferred relationship Some 2
Levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram oral tablet Is a Levothyroxine and liothyronine only product in oral dose form true Inferred relationship Some
Levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Liothyronine sodium true Inferred relationship Some 1
Levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram oral tablet Has unit of presentation Tablet (unit of presentation) true Inferred relationship Some
Levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram oral tablet Count of base of active ingredient deux false Inferred relationship Some
Levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Liothyronine sodium true Inferred relationship Some 1
Levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Levothyroxine sodium anhydrous true Inferred relationship Some 2
Levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram oral tablet Has presentation strength denominator value un false Inferred relationship Some 2
Levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram oral tablet This attribute specifies the denominator unit for the presentation strength of a product. Tablet (unit of presentation) true Inferred relationship Some 1
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start